# Hinge Health (HNGE.US)

Canonical: https://gigainvestors.com/s/HNGE

Analysis as of: 2026-10-16T07:29:04.676Z. 

Listing currency: USD. Reporting currency: USD.

## Verdict

Not enough history yet

Quality tests for Buy: not passed (profit record: fail; earnings resilience is evidence only). Published buy qualification: no.

Share price: $104.96 per share; close as of 2026-10-15.

## Checklist

### understandable: na

### moat: na

### economics: na

### management: na

### accounting: na

## Holders

- [Matthew McLennan](https://gigainvestors.com/FE): tracked 13F investor; follow the investor page for holding quarter and amounts.

## Price story

Up 170% since May 2025 · "Hinge Health outlines 25% revenue growth target for 2026 while expanding AI-driven care" (seekingalpha.com, Feb 2026)

Story as of 2026-10-16T09:58:53.347Z; price observation 2026-10-15.

- 2025-11-06: Hinge Health (HNGE) Sheds 15% After Swinging to Net Loss ([finance.yahoo.com](https://finance.yahoo.com/news/hinge-health-hnge-sheds-15-171128612.html))

- 2026-02-11: Hinge Health outlines 25% revenue growth target for 2026 while expanding AI-driven care ([seekingalpha.com](https://seekingalpha.com/news/4549921-hinge-health-outlines-25-percent-revenue-growth-target-for-2026-while-expanding-ai-driven?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news))

- 2026-08-05: HNGE Q2 Earnings Meet Estimates, Sales Top, '26 View Raised, Stock Up ([finance.yahoo.com](https://finance.yahoo.com/markets/stocks/articles/hnge-q2-earnings-meet-estimates-164000260.html))

## Owner memo

Memo as of 2026-10-16T08:06:05.509Z.

### How it makes money

Operates in health information services; annual sales are USD 587.9 million.

- Source: https://www.sec.gov/Archives/edgar/data/1673743/000162828026013808/hnge-20251231.htm (filed 2026-03-03); FY2025: revenue 587860000; grossProfit 469302000; margin = grossProfit / revenue.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-10-16); HNGE.US: Hinge Health, Inc. focuses on building a health system that scales and automates the delivery of care using technology. It designs its platform to address musculoskeletal system care (MSK), including acute injury, chronic pain, and post-surgical rehabilitation. The company also provides personalized and automated MSK care through AI-powered motion tracking technology and a proprietary electrical nerve stimulation wearable device. It primarily serves self-insured employers. The company was founded in 2012 and is headquartered in San Francisco, California.

### Why customers stay

Margins ranged from 66.3% to 79.8% during 2023–25.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-03-03); FY2023: grossProfit / revenue = 66.3%.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-03-03); FY2024: grossProfit / revenue = 77%.

- Source: https://www.sec.gov/Archives/edgar/data/1673743/000162828026013808/hnge-20251231.htm (filed 2026-03-03); FY2025: grossProfit / revenue = 79.8%.

### Where the cash goes

Paid no dividends in 3 years; bought back USD 65 million of shares.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-03-03); Dividend observations: [[2023,0],[2024,0],[2025,0]]. Zero only counted when supported by a complete cash-flow statement.

- Source: https://www.sec.gov/Archives/edgar/data/1673743/000162828026013808/hnge-20251231.htm (filed 2026-03-03); FY2025: cash repurchases 65028000 USD.

### Are managers owners

Insiders own 4.7% of the company.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-10-16); HNGE.US SharesStats.PercentInsiders = 4.749 percentage points; cache date 2026-10-16.

### What the price says

The price is 9.7 times annual sales; cash earnings are negative.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-03-03); Closing price 104.96 USD; reporting-to-trading FX 1; FY2025 annual sales per share 10.771203987027503; price multiple 9.744500255162793. FY2025 cash earnings/share -9.598109075251479. Closing-price date 2026-10-15.

## Monthly share-price history (USD per share)

- 2025-05: $38.84 per share

- 2025-06: $51.75 per share

- 2025-07: $44.95 per share

- 2025-08: $56.08 per share

- 2025-09: $49.08 per share

- 2025-10: $49.76 per share

- 2025-11: $48.91 per share

- 2025-12: $46.45 per share

- 2026-01: $34.90 per share

- 2026-02: $42.76 per share

- 2026-03: $38.56 per share

- 2026-04: $44.60 per share

- 2026-05: $56.21 per share

- 2026-06: $83.00 per share

- 2026-07: $74.71 per share

- 2026-08: $92.56 per share

- 2026-09: $97.24 per share

- 2026-10: $104.96 per share

## Annual estimated value (USD per share)

Historical values use today's bond yield for every fiscal year

Historical values use today's FX rate into trading currency for every fiscal year

Historical values use current restated fundamentals and current commodity classification; they are not point-in-time estimates

## Sources

[Original 10-K filing](https://www.sec.gov/Archives/edgar/data/1673743/000162828026013808/hnge-20251231.htm); period 2025-12-31, filed 2026-03-03.

Estimates depend on assumptions and are not guarantees or investment advice. Underlying data remains subject to its source licenses; public reading does not grant bulk redistribution rights.